col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

SAGE Publications: Clinical and Applied Thrombosis/Hemostasis
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―09 Safety Interval From Increased Viscosity After COVID-19 Vaccination Among Persons With Cerebrovascular Problems Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
2 [GO] 2021―Jun―30 Acetylsalicylic Acid and COVID-19 Prevention: A Comment Pathum Sookaromdee, Viroj Wiwanitkit
3 [GO] 2021―Jun―29 Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity Mehmet Gökhan Gönenli, Zeynep Komesli, Said İncir, Özlem Yalçın, Olga Meltem Akay
4 [GO] 2021―Jun―25 Clinical Features of COVID-19 Patients With Venous Thromboembolism Kai Liang, Ying Fu, Yi Kang, Huanzhang Shao, Jianxu Yang, Mingzhe Cui, Shuiting Zhai
5 [GO] 2021―Jun―18 Evaluation of Bleeding Rate and Time in Therapeutic Range in Patients Using Warfarin Before and During the COVID-19 Pandemic-Warfarin Treatment in COVID-19 Zeynep Yapan Emren, Oktay Şenöz, Ahmet Erseçgin, Sadık Volkan Emren
6 [GO] 2021―Jun―18 Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19 Beuy Joob, Viroj Wiwanitkit
7 [GO] 2021―Jun―02 An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination Bulent Kantarcioglu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, et al. (+7)
8 [GO] 2021―May―21 Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy Radu Crisan-Dabija, Alexandru Burlacu
9 [GO] 2021―May―20 The Meaning of D-Dimer value in Covid-19 Giulia Conte, Marco Cei, Isabella Evangelista, Alessandra Colombo, Josè Vitale, Antonino Mazzone, Nicola Mumoli
10 [GO] 2021―Apr―30 Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? Federico Cacciapuoti, Fulvio Cacciapuoti
11 [GO] 2021―Apr―30 Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression Haoting Zhan, Haizhen Chen, Chenxi Liu, Linlin Cheng, Songxin Yan, Haolong Li, Yongzhe Li
12 [GO] 2021―Apr―28 Blood Viscosity at the First Clinical Presentation in Fatal and Non-Fatal COVID-19: An Observation Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
13 [GO] 2021―Apr―20 Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Chatphatai Moonla, Darintr Sosothikul, Thita Chiasakul, Ponlapat Rojnuckarin, Noppacharn Uaprasert
14 [GO] 2021―Apr―09 Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection Sandra Lopez-Castaneda, Nallely García-Larragoiti, Alan Cano-Mendez, Kenia Blancas-Ayala, Guadalupe Damian-Vázquez, Ana Itzel Perez-Medina, et al. (+3)
15 [GO] 2021―Apr―08 ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study Joel G. Ray, Marian J. Vermeulen, Michael J. Schull, Alison L. Park
16 [GO] 2021―Apr―05 Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19 Luis O. Bobadilla-Rosado, Santiago Mier y Teran-Ellis, Gabriel Lopez-Pena, Javier E. Anaya-Ayala, Carlos A. Hinojosa
17 [GO] 2021―Mar―31 Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It Carlos A. Cañas, Felipe Cañas, Mario Bautista-Vargas, Fabio Bonilla-Abadía
18 [GO] 2021―Mar―30 Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic Serdar Farhan, Haroon Kamran, Birgit Vogel, Karan Garg, Ajit Rao, Navneet Narula, et al. (+9)
19 [GO] 2021―Mar―24 Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose Zhenzhou Wang, Zhe Du, Xiujuan Zhao, Fuzheng Guo, Tianbing Wang, Fengxue Zhu
20 [GO] 2021―Feb―11 Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis Azza Sarfraz, Zouina Sarfraz, Aminah Abdul Razzack, Gaurav Patel, Muzna Sarfraz
21 [GO] 2021―Feb―10 Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection Harry N. Magnani
22 [GO] 2021―Jan―15 Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Noppacharn Uaprasert, Chatphatai Moonla, Darintr Sosothikul, Ponlapat Rojnuckarin, Thita Chiasakul
23 [GO] 2020―Dec―29 Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis Chuanqi Cai, Yi Guo, Yun You, Ke Hu, Fei Cai, Mingxing Xie, et al. (+6)
24 [GO] 2020―Oct―20 COVID-19 and Hypercoagulability: A Review Asim Kichloo, Kirk Dettloff, Michael Aljadah, Michael Albosta, Shakeel Jamal, Jagmeet Singh, et al. (+4)
25 [GO] 2020―Oct―20 The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review Indra Wijaya, Rizky Andhika, Ian Huang
26 [GO] 2020―Oct―20 Prevalence and Risk Factors of Thromboembolism among Patients With Coronavirus Disease-19: A Systematic Review and Meta-Analysis Belayneh Kefale, Gobezie T. Tegegne, Amsalu Degu, Melaku Tadege, Desalegn Tesfa
27 [GO] 2020―Oct―15 Is Thrombophilic Genetic Profile Responsible for an Acute Ischemic Stroke in a COVID-19 Male Patient? Alexandru Burlacu, Bogdan Artene, Radu Crisan-Dabija, Iolanda Valentina Popa, Adrian Covic
28 [GO] 2020―Oct―08 A Retrospective Analysis of the Coagulation Dysfunction in COVID-19 Patients Xu Chen, Qinghua Wang, Min Xu, Chengbin Li
29 [GO] 2020―Sep―16 Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review Nicholas Kipshidze, Patrick Iversen, Thomas R. Porter, Nodar Kipshidze, Fakiha Siddiqui, George Dangas, Jawed Fareed
30 [GO] 2020―Sep―16 Anticoagulation in COVID-19: DDI Perspective Sajad Khiali, Taher Entezari-Maleki
31 [GO] 2020―Sep―04 Methodological Issues and Controversies in COVID-19 Coagulopathy: A Tale of Two Storms Samuel A Berkman, Victor F Tapson
32 [GO] 2020―Sep―02 Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic Faisal Alsayegh, Shaker A. Mousa
33 [GO] 2020―Aug―28 Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients Yuan Yu, Jie Tu, Bingxin Lei, Huaqing Shu, Xiaojing Zou, Ruiting Li, et al. (+3)
34 [GO] 2020―Aug―26 COVID-19, Antiphospholipid Syndrome and Thrombosis Sora Yasri, Viroj Wiwanitkit
35 [GO] 2020―Aug―26 Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events? Alexandru Burlacu, Simonetta Genovesi, Iolanda Valentina Popa, Radu Crisan-Dabija
36 [GO] 2020―Aug―21 Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic Kaveh Rezaei Bookani, Iva Minga, Manisha Chander, Ksenia Hankewych, Matthew Plassmeier, Alfonso Tafur
37 [GO] 2020―Aug―14 COVID-19 Associated Coagulopathy and Thrombotic Complications Zoubida Tazi Mezalek, Hajar Khibri, Wafaa Ammouri, Majdouline Bouaouad, Soukaina Haidour, Hicham Harmouche, et al. (+2)
38 [GO] 2020―Jul―31 COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response Apoorva Jayarangaiah, Pramod Theetha Kariyanna, Xiaoyi Chen, Amog Jayarangaiah, Abhishek Kumar
39 [GO] 2020―Jul―31 Coronavirus Disease and Acute Vascular Events Gundu H. R. Rao
40 [GO] 2020―Jul―29 Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan Jianpu Chen, Xiang Wang, Shutong Zhang, Bin Lin, Xiaoqing Wu, Yanfang Wang, et al. (+4)
41 [GO] 2020―Jul―29 Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications MA Haimei
42 [GO] 2020―Jul―24 Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19 Galit H. Frydman, Edward W. Boyer, Rosalynn M. Nazarian, Elizabeth M. Van Cott, Gregory Piazza
43 [GO] 2020―Jul―22 Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19? José A. Páramo
44 [GO] 2020―Jul―20 Viral Coagulopathy in Patients With COVID-19: Treatment and Care Nickolas Kipshidze, George Dangas, Christopher J. White, Nodar Kipshidze, Fakiha Siddiqui, Christopher R. Lattimer, et al. (+2)
45 [GO] 2020―Jul―17 COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation Wolfgang Miesbach, Michael Makris
46 [GO] 2020―Jul―13 Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium? Nil Guler, Fakiha Siddiqui, Jawed Fareed
47 [GO] 2020―Jul―10 Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020 Eduardo Ramacciotti, Ariane Scarlatelli Macedo, Rodrigo Bruno Biagioni, Roberto Augusto Caffaro, Renato Delascio Lopes, João Carlos Guerra, et al. (+8)
48 [GO] 2020―Jul―10 Reducing the Risk of Venous Thrombosis During Self-Isolation and COVID-19 Pandemic for Patients With Cancer: Focus on Home Exercises Prescription Ufuk Demirci, Hande Ozdemir, Derya Demirbag-Kabayel, Elif G. Umit, Ahmet Muzaffer Demir
49 [GO] 2020―Jul―03 COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets Erkan Cure, Medine Cumhur Cure
50 [GO] 2020―Apr―06 Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients Beuy Joob, Viroj Wiwanitkit


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.006 sec